Treatment with subantimicrobial dose doxycycline improves the efficacy of scaling and root planing in patients with adult periodontitis

Citation
Jg. Caton et al., Treatment with subantimicrobial dose doxycycline improves the efficacy of scaling and root planing in patients with adult periodontitis, J PERIODONT, 71(4), 2000, pp. 521-532
Citations number
40
Categorie Soggetti
Dentistry/Oral Surgery & Medicine","da verificare
Journal title
JOURNAL OF PERIODONTOLOGY
ISSN journal
00223492 → ACNP
Volume
71
Issue
4
Year of publication
2000
Pages
521 - 532
Database
ISI
SICI code
0022-3492(200004)71:4<521:TWSDDI>2.0.ZU;2-0
Abstract
Background: In a previous study, subantimicrobial dose doxycycline (SDD) si gnificantly improved clinical parameters associated with periodontal health in patients with adult periodontitis (AP) when used as an adjunct to a mai ntenance schedule of supragingival scaling and dental prophylaxis. In this double-blind, placebo-controlled, parallel-group, multicenter study, the ef ficacy and safety of SDD were evaluated in conjunction with scaling and roo t planing (SRP) in patients with AP. Methods: Patients (n = 190) received SRP at the baseline visit and were ran domized to receive either SDD 20 mg bid or placebo bid for 9 months. Effica cy parameters included the per-patient mean changes in clinical attachment level (CAL) and probing depth (PD) from baseline, the per-patient percentag es of tooth sites with attachment loss (AL) greater than or equal to2 mm an d greater than or equal to3 mm from baseline, and the per-patient percentag e of tooth sites with bleeding on probing. Prior to analysis, tooth sites w ere stratified by the degree of disease severity evident at baseline. Results: In tooth sites with mild to moderate disease and severe disease (n = 183, intent-to-treat population), improvements in CAL and PD were signif icantly greater with adjunctive SDD than with adjunctive placebo at 3, 6, a nd 9 months (all P <0.05), In tooth sites with severe disease, the per-pati ent percentage of sites with AL <greater than or equal to>2 mm from baselin e to month 9 was significantly lower with adjunctive SDD than with adjuncti ve placebo (P<0.05). Improvements in clinical outcomes occurred without det rimental shifts in the normal periodontal flora or the acquisition of doxyc ycline resistance or multiantibiotic resistance. SDD was well tolerated, wi th a low incidence of discontinuations due to adverse events. Conclusions: The adjunctive use of SDD with SRP is more effective than SRP alone and may represent a new approach in the long-term management of AP.